Académique Documents
Professionnel Documents
Culture Documents
MENTOR
DR.SARALA
CASE SCENARIO
4 months old/ Malay/ Boy
Was brought to casualty due to fever for 1 day
FURTHER HISTORY
Fever
any documented temperature?
rash?
bleeding tendency?
from dengue area?
contact with ill person?
child taken care by whom?
hx of recent travelling?
URTI sx?
UTI sx?
Diarrhea / Vomitting?
Irritability, Inconsolable cry?
Feeding history/Urine output?
Mother on traditional medication?
Mother applies ointment to the baby?
H/O jaundice?
FURTHER HISTORY
WHAT ASSESSMENT
YOU WOULD LIKE TO
DO?
Primary assessment
ABCDE
Secondary assessment
Head to Toe
General Condition
PRIMARY ASSESSMENT
Airway
Patent, No secretion / No foreign body
Breathing
Effort: RR 45, no SCR, ICR, no nasal flaring,
Efficacy: Not tachypneic, SpO2 98% under room air, on
auscultation: lungs clear with good air entry bilaterally
Effect: HR 142 bpm, good pulse volume, CRT < 2 sec, warm
peripheries
Circulation
Well perfused, Heart rate 142 bpm, CRT < 2 sec, good pulse
volume, BP 90/50
Disability
No abnormal posture, pupils bilateral equal and reactive,
DXT 4.8
Exposure
No skin rashes, temperature 39.9 degree celcius
SECONDARY ASSESSMENT
DIFFERENTIAL DIAGNOSIS
Urinary obstruction
Nephrolithiasis
Viral fever, dengue fever
WHAT
INVESTIGATION
WOULD YOU LIKE TO
DO?
FBC
UFEME
URINE Culture and Sensitivity
BLOOD Culture and Sensitivity
FBC
WBC
Hb
HCT
MCV
MCH
Platelet
: 27.96
: 11
: 33.1
: 61
: 18
: 433
pH
:5
Leu :500/ul
Nitrate
:negative
Pus cell
:15-20
RBC
:3-4
PROVISIONAL
DIAGNOSIS?
IV Antibiotics
IV Cefuroxime(100mg/kg/day) TDS or
IV Cefotaxime(100mg/kg/day) TDS or
IV Gentamicin 5-7mg/kg/day) OD
Continue intravenous antibiotic until child is
afebrile for 2-3 days and then switch to
appropriate oral therapy after culture results
e.g. Cefuroxime, for total of 10-14 days.
PROGRESS OF PATIENT
IV Cefuroxime was started at Day 1 of admission
after r/v UFEME
Temperature settled after 36 hours of antibiotics
started
Urine C&S available at day 3 of admission
PATIENTS PROGRESS
Patient was discharged at Day 5 after complete IV
Cefuroxime.
INTRODUCTION
kidney
ureter
bladder
urethra.
UROPATOGENS
PATOGENESIS
Risk factors
Although all individuals are susceptible to UTI,
most remain infection free during childhood
because of the innate ability to resist uropathogen
attachment.
Anatomic abnormalities
_ predispose children to UTI because of inadequate clearance
of uropathogens.
It
Surgical
divided
primary
VUR
secondary VUR ( it results from high pressure
voiding secondary to posterior urethral valve,
neuropathic bladder or voiding dysfunction)
Functional
eg;
abnormalities
neurogenic bladder
Inability to empty the bladder, frequently
results in urinary retention, urinary stasis,
and suboptimal clearance of bacteria from the
urinary tract.
Clean intermittent catheterization (CIC) is
helpful for emptying the neurogenic bladder,
but catheterization itself may introduce
bacteria to this normally sterile space.
In children between 2
and 5 years of age,the
most common
presenting symptoms
abdominal pain
fever
vomitting
strong-smelling
urine
Asymptomatic bacteriuria
Positive urine culture without any manifestations of
infection
Occurs almost exclusively in girls
Benign and does not cause renal injury, except in pregnant
women, in whom asymptomatic bacteriuria, if left
untreated, can result in a symptomatic UTI
PHYSICAL EXAMINATION
MANAGEMENT
NICE GUIDELINE:
Dehydration
-most common complication of UTI in the
pediatric population.
-IV fluid replacement is necessary in more severe
cases.
Untreated UTI may progress to renal involvement
with systemic infection (e.g., urosepsis).
Long-term complications include renal
parenchyma scarring, hypertension, decreased
renal function, and, in severe cases, renal failure.
MESSAGE:
Most cases of UTI are simple, uncomplicated, and
respond readily to outpatient antibiotic
treatments without further sequelae.
Appropriate treatment, imaging, and follow-up
prevent long-term sequelae in patients with more
severe infections or chronic infections.
Mild VUR usually resolves without permanent
damage.
REFERENCE:
Paediatric protocol
Medscape
Nice guideline
THANK YOU